Related Experiment Video
Updated: Jun 27, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
Inflammatory myopathy in hemiatrophy resulting from linear scleroderma.
R F Richardson1, B Katirji, M S Rodgers
1From the Department of *Nerology and dagger Pathology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Linear scleroderma causes hemiatrophy, a rare condition with unknown origins. This study details a patient experiencing inflammatory myopathy alongside hemiatrophy linked to linear scleroderma.
Area of Science:
- Dermatology
- Rheumatology
- Neurology
Background:
- Linear scleroderma is a rare autoimmune condition characterized by localized sclerotic skin changes.
- Hemiatrophy, a potential complication, involves the underdevelopment or wasting of one side of the body.
- The etiology of linear scleroderma and its association with hemiatrophy remain poorly understood.
Purpose of the Study:
- To present a case study of a patient with hemiatrophy secondary to linear scleroderma.
- To investigate the potential link between inflammatory myopathy and hemiatrophy in the context of linear scleroderma.
Main Methods:
- Case report detailing clinical presentation, diagnostic workup, and treatment of a patient with linear scleroderma and hemiatrophy.
- Review of relevant medical literature on linear scleroderma, hemiatrophy, and inflammatory myopathies.
Main Results:
- The patient presented with hemiatrophy and concurrent inflammatory myopathy.
- Diagnostic findings supported the diagnosis of inflammatory myopathy in the affected hemiatrophic region.
Conclusions:
- Inflammatory myopathy may be an underrecognized complication of hemiatrophy associated with linear scleroderma.
- Further research is warranted to elucidate the pathogenesis and clinical implications of this association.
Related Concept Videos
Myocarditis I: Introduction
Cross-bridge Cycle
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
